Automated methods and systems for washing platelet concentrates

US2016333315A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016333315-A1
Application numberUS-201615193397-A
CountryUS
Kind codeA1
Filing dateJun 27, 2016
Priority dateApr 7, 2011
Publication dateNov 17, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Automated systems and methods for providing platelet concentrates and synthetic storage media with reduced residual plasma volumes are disclosed. The disclosed systems and methods reduce the residual volume of plasma in platelet concentrate to obtain a platelet product having a volume of plasma that is approximately 5% or less of the total platelet product volume. The disclosed systems and methods also reduce the residual volume of plasma in platelet concentrate to obtain a washed platelet product, wherein the volume of plasma in the washed platelet product is approximately 1% or less of the total washed platelet product volume. Storage media for platelets including less than approximately 10% plasma are also disclosed.

First claim

Opening claim text (preview).

1 - 23 . (canceled) 24 . An automated method of washing platelets comprising: providing an automated separation device comprising a platelet concentration chamber, introducing a blood product including at least platelets and plasma into said chamber, separating said blood product to obtain a platelet concentrate, said platelet concentrate comprising platelets suspended in a residual volume of plasma, introducing a wash solution into said separation device, and removing residual plasma from said chamber to provide a washed platelet product comprising platelets, wash solution and plasma, wherein the volume of plasma in said washed platelet product is 1% or less of the total washed platelet product. 25 . The method of claim 24 comprising sequentially introducing two or more batches of said blood product wherein each sequential introduction is followed by said separation, said wash solution introduction and said removal step to arrive at said volume of plasma. 26 - 32 . (canceled) 33 . A method of washing platelets comprising: providing an apheresis device, separating platelets suspended in plasma in said apheresis device to obtain concentrated platelets suspended in a reduced volume of plasma, collecting substantially all of said concentrated platelet suspension, removing any residual plasma remaining in said apheresis device, re-suspending said concentrated platelets in a volume of aqueous additive solution, wherein said aqueous additive solution comprises: from about 45 to about 120 mM sodium chloride; from about 5 to about 15 mM sodium citrate; from about 20 to about 40 mM sodium acetate; from about 0.05 to about 12 mM phosphate; from about 0.05 to about 3 mM magnesium ion; from about 0.05 to about 10 mM potassium chloride; from about 5 to about 40 mM sodium bicarbonate; and from about 0.5 to about 20 mM glucose; and conveying said resuspended platelets into said apheresis device to remove additional plasma from said platelet suspension to provide a concentrated platelet product comprising platelets, said aqueous additive solution and plasma, wherein the volume of plasma in said platelet product is 5% or less of the total platelet product volume.

Assignees

Inventors

Classifications

  • Drugs for disorders of the blood or the extracellular fluid · CPC title

  • Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents · CPC title

  • C12N5/0644Primary

    Platelets; Megakaryocytes · CPC title

  • Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifuging · CPC title

  • Platelets; Megacaryocytes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016333315A1 cover?
Automated systems and methods for providing platelet concentrates and synthetic storage media with reduced residual plasma volumes are disclosed. The disclosed systems and methods reduce the residual volume of plasma in platelet concentrate to obtain a platelet product having a volume of plasma that is approximately 5% or less of the total platelet product volume. The disclosed systems and meth…
Who is the assignee on this patent?
Fenwal Inc
What technology area does this patent fall under?
Primary CPC classification C12N5/0644. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Nov 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).